Skip to main content

Beverly Hills  ·  Century City

Dr. Carlo Honrado

M.D., F.A.C.S.  —  Facial Plastic Surgery

All Insights

AI-Generated Content Disclosure (CA AB 3030) — This article was researched and drafted by Mentis Intelligence, an AI system operated by Carlo P. Honrado M.D., Inc. It is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Its material claims are checked against cited public sources under the governed publishing policy. No physician authorship or individualized clinical judgment is claimed. To speak with a human member of our team, please contact us online or call our office directly.

Practice NewsNon-Surgical Treatments4 min readJuly 24, 2026

Neck Injectables Review: 2026 Evidence Update

CH

Dr. Carlo Honrado, MD, FACS

Double board-certified facial plastic & reconstructive surgeon · AI-assisted editorial

Governed public-source and claim verification

A July 2026 clinical review has brought new attention to injectable treatments for neck aging, summarizing evidence from 24 studies and 887 patients on hyaluronic acid fillers, poly-L-lactic acid, and calcium hydroxylapatite for horizontal neck lines, mild laxity, and crepey skin. The review suggests injectables may offer a non-surgical option for selected patients, while emphasizing limited long-term data and the need for careful physician evaluation.

What did the July 2026 review find about neck injectables?

Neck injectables are non-surgical treatments placed into or beneath neck skin to soften lines, improve texture, or stimulate collagen production. In July 2026, a review summarized in The Derm 5 examined injectable treatments used specifically for neck rejuvenation, including cross-linked and non–cross-linked hyaluronic acid, poly-L-lactic acid, and calcium hydroxylapatite formulations (The Derm 5, July 14, 2026).

The review analyzed 24 studies involving 887 patients, making it one of the more current structured summaries of injectable evidence for the neck area. The concerns studied included:

  1. Horizontal neck lines, sometimes called necklace lines
  2. Mild skin laxity, meaning looseness without advanced hanging skin
  3. Crepey skin texture, referring to thin, finely wrinkled skin
  4. Dermal thinning, where skin may appear less firm or resilient

According to the July 2026 review summarized by The Derm 5, early results were promising, but the evidence base remained cautious because most included studies were small, used varied outcome measures, and had limited long-term follow-up.

The review’s key practical message was not that injectables replace surgery. Rather, it suggested that specific injectable products may have a role for patients with mild-to-moderate neck aging who want improvement in lines, texture, and firmness without pursuing a neck lift at that time.

Which injectable products were reviewed for neck aging?

Hyaluronic acid is a naturally occurring sugar molecule used in many dermal fillers to add hydration, softness, and volume. Poly-L-lactic acid is a biostimulatory injectable that encourages collagen formation over time. Calcium hydroxylapatite is another biostimulatory filler, often used in diluted or hyperdiluted form for skin quality and firmness rather than simple volume replacement.

The July 2026 review focused on three major categories:

  • Hyaluronic acid fillers, including cross-linked and non–cross-linked formulations
  • Poly-L-lactic acid, commonly associated with Sculptra-type products
  • Calcium hydroxylapatite, including hyperdilute Radiesse-type formulations

According to the American Academy of Dermatology’s clinical guideline resources, dermatologic procedures and aesthetic interventions are generally evaluated through safety, patient selection, and evidence quality. That framework is relevant here because the neck is a technically sensitive area with thinner skin and visible contours.

A July 2026 aesthetic industry report also noted that neck treatments are increasingly discussed as complements to facelift and facial rejuvenation planning, reflecting the broader trend toward combined approaches rather than one-size-fits-all procedures (Estado de Minas).

How did hyaluronic acid perform for horizontal neck lines?

Hyaluronic acid fillers showed durable improvement in horizontal neck lines in the studies reviewed. In one cohort using an HA product identified as VYC-12, 46 of 50 patients had at least a 1-point reduction in line severity, according to the July 2026 review summarized by The Derm 5.

That finding is notable because horizontal neck lines can be difficult to improve with skin care alone. These lines may be influenced by skin quality, repeated motion, anatomy, and age-related changes. HA fillers are already widely used in facial aesthetic medicine, including the cheeks, lips, and jawline, but the neck has different safety and technique considerations.

The review described HA as helpful for line softening, particularly when the main concern is etched horizontal lines rather than significant loose skin. However, the same evidence summary cautioned that outcomes varied by product, technique, and study design.

Key HA-related figures from the review include:

  1. 50 patients in one VYC-12 cohort
  2. 46 patients achieving at least a 1-point severity reduction
  3. 24 total studies in the review
  4. 887 total patients across all included injectable categories

What did hyperdilute calcium hydroxylapatite show?

Hyperdilute calcium hydroxylapatite refers to CaHA filler diluted with additional fluid so it can be spread more broadly for skin quality and collagen stimulation rather than placed as a firm volumizing product. In the July 2026 review, hyperdilute CaHA showed improvement in several neck-aging measures.

According to The Derm 5, studies in the review reported:

  • 86% of patients had improvement in neck lines
  • 82% of patients had improvement in neck laxity
  • 15% increase in dermal thickness was observed at day 120

Those figures are important because they suggest a potential biologic effect on skin structure, not only temporary filling. Calcium hydroxylapatite is frequently discussed as a collagen-stimulating material in aesthetic medicine, and hyperdilute protocols are part of a growing category of treatments aimed at firmness and texture.

The broader aesthetic technology landscape has also emphasized minimally invasive tools, including injectables, radiofrequency, ultrasound, laser treatments, and regenerative approaches, as part of customized skin-quality programs (Madison Plastic Surgery). However, such reports should be read as general industry context, not as proof that any one treatment is appropriate for a specific patient.

What concerns did the review raise about PLLA in the neck?

Poly-L-lactic acid refers to an injectable biostimulatory material designed to gradually stimulate collagen. In the July 2026 review, PLLA-type treatments were described as potentially offering longer-lasting improvement in atrophy and laxity compared with some other injectables, according to The Derm 5.

However, the review also emphasized that neck nodules remain a concern. Nodules are small lumps or areas of firmness that may occur after certain injectable treatments. The neck’s thin skin and visible surface make this risk particularly relevant.

This is why product selection, dilution, placement depth, and injector experience matter. The review did not suggest that PLLA is universally inappropriate for the neck, but it did reinforce that the neck is a specialized treatment zone. In plain terms: a product that performs well in the face may still require different judgment when used in the neck.

The review also stated that studies had “heterogeneous outcome measures” and “limited long-term data,” according to the July 2026 evidence summary reported by The Derm 5. Those two phrases are important because they explain why clinicians may interpret the findings cautiously.

Why does this matter for patients considering facial rejuvenation?

Neck aging is increasingly viewed as part of facial rejuvenation rather than a separate cosmetic concern. A refreshed face may appear less harmonious if the neck has prominent lines, thin texture, or laxity. This is one reason many aesthetic practices now discuss the lower face and neck together when reviewing options such as fillers, skin tightening, facelift, mini-facelift, or neck lift.

The July 2026 review matters for prospective patients because it helps define where injectables may fit:

  1. For horizontal lines: HA fillers may soften etched lines in selected patients.
  2. For crepey texture: Hyperdilute CaHA may help improve skin quality and dermal thickness.
  3. For mild laxity: CaHA and PLLA-type products may support collagen-related firmness.
  4. For significant loose skin: Surgery may still be the more appropriate category to discuss with a qualified surgeon.
  5. For uncertain cases: Energy-based devices, injectables, skin care, or surgery may be considered in combination.

Industry coverage in 2026 has also noted interest in adjunctive treatments to facelift surgery, including skin-quality and regenerative procedures (Estado de Minas). Separately, aesthetic technology commentary has described a continuing trend toward “minimally invasive” approaches that involve shorter downtime than traditional surgery (Madison Plastic Surgery).

Are neck injectables a replacement for a neck lift?

Neck injectables are not the same as a neck lift. A neck lift is a surgical procedure intended to address deeper structural laxity, excess skin, and neck contouring concerns. Injectables generally aim to improve surface lines, skin quality, and mild laxity.

This distinction is central to realistic expectations. The July 2026 review supports injectables as part of an evolving toolkit, not as a permanent or universal alternative to surgery. Individual results vary, and patient anatomy, skin thickness, laxity severity, prior treatments, and medical history all affect treatment planning.

Patients should also understand that many injectable approaches are incremental. Some treatments may require a series of sessions, maintenance, or combination with other modalities. The review’s evidence base was limited by smaller studies and inconsistent follow-up periods, so definitive long-term claims should be avoided.

According to the American Academy of Dermatology’s clinical quality resources, evidence-based care depends on appropriate evaluation and guideline-informed decision-making. For patients, that means asking questions about alternatives, expected recovery, risks, and how success will be measured.

What questions should patients ask before considering neck injectables?

Patients considering neck injectables may want to ask a qualified physician:

  • Which concern is being treated: lines, laxity, crepey skin, or volume loss?
  • Is hyaluronic acid, PLLA, or CaHA most appropriate for this concern?
  • Is the product being used on-label or off-label in the neck?
  • What are the risks of lumps, nodules, swelling, bruising, or asymmetry?
  • How many sessions are typically needed?
  • What alternatives exist, including laser, radiofrequency, ultrasound, skin care, or surgery?
  • How will improvement be assessed: photographs, line scales, skin texture, or patient-reported outcomes?

The July 2026 review’s practical implication is that neck injectables can be meaningful, but they require individualized assessment. The neck is visible, mobile, and anatomically delicate, so conservative planning and careful technique are important.

FAQ

What are neck injectables?

Neck injectables are non-surgical treatments placed into the neck skin or deeper tissue to soften horizontal lines, improve crepey texture, or stimulate collagen. Common categories include hyaluronic acid, calcium hydroxylapatite, and poly-L-lactic acid.

What did the July 2026 review study?

The July 2026 review summarized 24 studies and 887 patients treated with injectable products for neck aging. It focused on horizontal neck lines, laxity, crepey skin, and dermal thickness.

Which injectable showed dermal thickening?

Hyperdilute calcium hydroxylapatite showed a 15% increase in dermal thickness at day 120, according to the July 2026 review summarized by The Derm 5. It also improved neck lines in 86% and laxity in 82% of patients in reported studies.

Are hyaluronic acid fillers useful for neck lines?

Hyaluronic acid fillers may help soften horizontal neck lines in selected patients. In one VYC-12 cohort reviewed in July 2026, 46 of 50 patients had at least a 1-point reduction in line severity.

What is the main caution with PLLA in the neck?

The main caution is the risk of nodules, or small lumps, in the neck area. The July 2026 review noted this concern and emphasized the importance of experienced injectors, careful product selection, and realistic expectations.


This article was produced by Mentis Intelligence for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Individual results vary. New techniques and devices should be discussed with a qualified physician. For a consultation with Dr. Carlo Honrado MD, FACS, contact (310) 286-0043 or visit drhonrado.com/contact. Content generated by AI (Mentis Intelligence) per California AB 3030 disclosure requirement.

For patients in Beverly Hills, Century City, and the greater Los Angeles area who want to discuss facial and neck rejuvenation options, appointments may be requested through the practice’s contact page.

Share
neck injectableshyaluronic acid fillerscalcium hydroxylapatiteneck rejuvenation
MI

Mentis Intelligence

AI SystemGoverned Verification

Mentis Intelligence is the AI-powered editorial system of Dr. Carlo Honrado's practice. It researches, drafts, and formats public educational content using governed source and claim verification. Physician review is stated only when a corresponding review record exists.

All content published on drhonrado.com is for educational purposes only and does not constitute medical advice. Please consult Dr. Honrado directly for a personalized evaluation.

Continue reading

01

PRF Under Eyes Beverly Hills: What to Know

5mJul 23, 2026
02

HA Fillers: FDA Approvals Expand Options

4mJul 3, 2026
03

Short-Acting Neuromodulator Approved in Canada

4mJun 29, 2026
Back to Insights

Stay Connected

Questions about your care options?

Our team is here to answer your questions and guide you toward the right next step — in a private, unhurried consultation.

Book a Consultation
Ask Mentis